determin
whether
contribut
immun
respons
lung
ifv
infect
first
intranas
infect
wildtyp
wt
mice
lethal
dose
ifv
plaqu
form
unit
pfu
mous
ifvinfect
wt
mice
appear
visibl
ill
ruffl
fur
reduc
oral
intak
day
infect
wherea
mice
appear
activ
wt
mice
consist
appar
activ
final
surviv
rate
day
infect
significantli
improv
mice
compar
wt
mice
fig
histopatholog
analysi
ifvinfect
lung
day
reveal
lung
inflamm
obviou
day
wt
mice
much
less
sever
mice
fig
given
inflammatori
cytokineschemokin
link
lung
damag
sever
influenza
analys
infiltr
cell
cytokinechemokin
level
bronchoalveolar
lavag
fluid
balf
collect
ifvinfect
lung
wt
mice
consist
patholog
data
total
number
infiltr
cell
balf
mice
decreas
compar
wt
mice
day
ifv
infect
fig
supplementari
fig
attribut
signific
decreas
neutrophil
compris
major
subpopul
infiltr
cell
fig
contrast
number
b
natur
killer
cell
well
macrophag
significantli
alter
balf
lung
fig
level
inflammatori
cytokin
chemokin
ie
report
contribut
lung
also
decreas
balf
mice
compar
wt
mice
day
infect
fig
addit
level
balf
mice
remain
lower
wt
mice
day
infect
data
indic
host
contribut
cytokinechemokin
product
includ
neutrophil
chemoattract
earli
time
point
ifv
infect
influenc
subsequ
inflammatori
cell
recruit
lung
patholog
later
time
point
collect
deplet
attenu
sever
influenza
pneumonia
improv
host
mortal
mice
activ
innat
immun
respons
ifv
regul
antivir
protect
evalu
impact
defici
antiifv
protect
first
analys
viral
copi
number
ifvinfect
lung
wt
mice
day
follow
ifv
infect
deplet
larg
affect
viral
copi
number
ifvinfect
lung
fig
typei
interferon
primari
factor
induc
host
resist
ifv
particular
induct
late
stage
ifv
infect
essenti
protect
contrast
cytokinechemokin
product
signific
differ
observ
product
infect
lung
wt
mice
fig
notabl
level
typeii
interferon
significantli
lower
lung
mice
wt
mice
day
day
infect
fig
unknown
reason
next
assess
induct
humor
acquir
immun
ifv
mice
wt
mice
infect
ifv
day
first
infect
repres
second
infect
product
virusspecif
antibodi
analys
day
second
infect
deplet
mice
affect
neither
product
virusspecif
igg
serum
virusspecif
iga
lung
mucosa
fig
collect
data
suggest
dispens
induct
protect
immun
ifv
infect
mice
macrophag
dendrit
cell
known
compris
earli
sourc
inflammatori
cytokin
typei
interferon
pulmonari
ifv
deplet
affect
macrophag
function
owe
reduc
activ
atp
product
via
thu
focus
function
macrophag
dendrit
cell
examin
whether
macrophag
dendrit
cell
requir
cytokinechemokin
product
respons
ifv
alveolar
macrophag
amf
thioglycolateinduc
periton
macrophag
tgmf
bone
marrowderiv
macrophag
bmmf
bone
marrowderiv
convent
dendrit
cell
cdc
ligandinduc
plasmacytoid
dendrit
cell
prepar
wt
mice
brought
contact
ifv
vitro
product
measur
cytokinechemokin
product
respons
ifv
decreas
amf
fig
tgmf
fig
bmmf
fig
furthermor
deplet
bmmf
also
attenu
cytokinechemokin
product
respons
pathogenassoci
molecular
pattern
pamp
addit
ifv
lp
supplementari
fig
poli
c
supplementari
fig
imiquimod
supplementari
fig
howev
deplet
affect
product
cdc
fig
fig
respons
ifv
thu
reduc
cytokinechemokin
product
macrophag
respons
ifv
dendrit
cell
like
account
least
part
attenu
influenza
pneumonia
mice
ifv
recogn
pattern
recognit
receptor
tolllik
receptor
retino
acid
induc
gene
activ
signal
pathway
although
macrophag
exhibit
reduc
remain
unclear
whether
also
influenc
activ
transcript
factor
induc
express
inflammatori
thu
express
level
target
gene
tnf
ifvstimul
wt
bmmf
analys
quantit
polymeras
chain
reaction
qpcr
method
express
level
tnf
mrna
decreas
bmmf
follow
ifv
stimul
fig
next
nuclear
transloc
ifvstimul
bmmf
examin
immunoblot
notabl
protein
level
nuclear
extract
bmmf
lower
wt
cell
start
point
h
remain
lower
observ
time
ifv
infect
fig
transloc
cytoplasm
nucleu
usual
suppress
inhibitor
howev
kinas
ikk
phosphoryl
therebi
promot
proteasom
degrad
signal
pathway
thu
analys
ikk
cytoplasm
extract
ifvinfect
wt
bmmf
express
phosphoryl
level
show
appar
differ
wt
bmmf
fig
howev
express
level
markedli
increas
bmmf
start
point
h
remain
higher
wt
cell
observ
time
ifv
stimul
fig
turn
lower
proport
phosphoryl
bmmf
ifv
stimul
fig
taken
togeth
find
indic
deplet
result
accumul
cytoplasm
suppress
activ
respons
ifv
stimul
macrophag
macrophag
exhibit
defect
atp
product
via
thu
next
examin
whether
ifv
infect
affect
atp
level
bmmf
atp
level
wt
bmmf
decreas
level
cell
h
ifv
infect
wherea
cell
maintain
atp
level
ifv
infect
fig
cell
starv
adenosin
monophosphateactiv
protein
amp
activ
kinas
ampk
activ
accordingli
phosphoryl
level
increas
wt
bmmf
ifv
infect
fig
bmmf
show
increas
phosphoryl
level
start
point
reflect
decreas
atp
level
fig
sustain
phosphoryl
ifv
infect
fig
notabl
amount
protein
increas
ifv
stimul
bmmf
fig
ampk
known
suppress
signal
via
sever
pathway
hypothes
defect
atp
product
via
glycolysi
result
ampk
activ
deplet
also
affect
ifvinduc
signal
macrophag
address
wt
bmmf
infect
ifv
presenc
glycolysi
inhibitor
mitochondri
oxid
phosphoryl
inhibitor
oligomycin
vehicl
inflammatori
cytokinechemokin
product
analys
oligomycin
treatment
decreas
inflammatori
cytokinechemokin
product
wt
bmmf
level
cell
ampk
activ
aicar
also
decreas
inflammatori
cytokinechemokin
product
wt
bmmf
level
cell
fig
next
examin
whether
ampk
activ
via
glycolysi
defect
relat
accumul
observ
bmmf
fig
address
issu
ifvinfect
wt
bmmf
treat
without
analys
treatment
impact
either
total
phosphoryl
level
wherea
total
phosphoryl
level
increas
ifvinfect
wt
bmmf
fig
nuclear
level
decreas
fig
result
indic
ampk
activ
via
glycolysi
defect
attenu
signal
independ
accumul
ifvinfect
macrophag
turn
next
examin
whether
accumul
alon
could
attenu
signal
ifvinfect
macrophag
address
possibl
ifvinfect
wt
bmmf
treat
without
phosphoryl
inhibitor
bay
bay
treatment
decreas
phosphoryl
level
increas
total
level
without
affect
total
phosphoryl
level
ifvinfect
wt
bmmf
fig
condit
bay
treatment
decreas
nuclear
level
wt
bmmf
h
ifv
infect
fig
bay
treatment
also
decreas
inflammatori
cytokinechemokin
product
wt
bmmf
level
cell
fig
thu
deplet
independ
caus
ampk
activ
accumul
could
separ
attenu
signal
independ
macrophag
studi
shown
pathway
contribut
influenza
pneumonia
mice
deplet
mice
reduc
inflammatori
cytokinechemokin
product
infiltr
inflammatori
cell
ifvinfect
lung
improv
mortal
rate
macrophag
deplet
also
attenu
cytokinechemokin
product
respons
ifv
infect
suppress
signal
pathway
suppress
macrophag
appear
mediat
two
independ
mechan
accumul
ampk
activ
fig
although
ampk
activ
suppress
signal
pathway
macrophag
unclear
sever
report
pathway
might
contribut
suppress
signal
pathway
consid
dispens
antiifv
immun
deplet
alter
viral
burden
elev
induct
antivir
adapt
b
cell
respons
ifvinfect
mice
thu
innat
mechan
independ
pathway
may
play
domin
role
protect
immun
ifv
type
ii
interferon
product
reduc
lung
mice
compar
lung
wt
mice
day
day
ifv
infect
fig
express
regul
deplet
might
affect
express
ifv
infect
mice
essenti
viral
howev
presenc
ifv
infect
amelior
sever
inflamm
lung
although
much
reduct
level
deplet
affect
ifvmedi
lung
injuri
remain
unclear
supplement
might
support
therapi
ifvinfect
lung
diseas
base
inhibit
promot
atp
product
via
glycolysi
activ
ampk
activ
atp
concentr
decreas
thu
deplet
activ
ampk
therebi
suppress
signal
macrophag
notabl
protein
level
increas
ifv
infect
treat
wt
macrophag
wherea
basal
protein
level
compar
wt
macrophag
fig
infecti
stress
might
boost
ampk
signal
increas
amount
protein
macrophag
combin
energi
stress
besid
ampk
also
influenc
cytokinechemokin
transcript
thu
activ
might
also
contribut
cytokinechemokin
product
independ
ampk
macrophag
addit
ampk
also
accumul
macrophag
although
activatedphosphoryl
level
compar
less
phosphoryl
macrophag
wt
cell
ifv
infect
activ
suppress
inhibitor
asparaginyl
hydroxylas
hydroxyl
subunit
molecul
includ
although
hydroxyl
report
affect
stabil
might
influenc
phosphoryl
state
macrophag
activ
depend
invasionpromot
membran
proteas
macrophag
cancer
recent
report
monooxygenas
mtor
signal
also
promot
activ
cancer
although
whether
relat
inflamm
unclear
mtor
contribut
inflammatori
thu
may
function
hub
among
molecul
ampk
signal
pathway
orchestr
inflamm
metabol
invas
macrophag
conclus
macrophag
act
contribut
sever
influenza
pneumonia
dispens
host
protect
ifv
thu
inhibit
might
repres
one
like
therapeut
target
control
sever
ifv
infect
without
affect
viral
clearanc
mice
previous
riken
center
development
biolog
cdb
access
http
mice
backcross
least
time
onto
mice
mice
purchas
clea
japan
inc
tokyo
japan
anim
hous
specif
pathogenfre
condit
experi
approv
institut
anim
care
use
committe
kitasato
univers
medic
center
anim
treat
accord
regul
anim
experi
kitasato
univers
fluorescein
isothiocyan
fitc
conjug
clone
fitcconjug
clone
phycoerythrin
pe
conjug
clone
biotinconjug
clone
peridinin
chlorophyl
conjug
clone
conjug
clone
monoclon
antibodi
purchas
biolegend
san
diego
ca
lp
escherichia
coli
poli
c
purchas
sigmaaldrich
st
loui
mo
imiquimod
purchas
invivogen
san
diego
ca
oligomycin
purchas
merck
millipor
billerica
aicar
purchas
cell
signal
technolog
danver
bay
purchas
wako
pure
chemic
industri
osaka
japan
mice
anesthet
infect
pfu
unless
otherwis
indic
mouseadapt
ifv
strain
isotyp
kindli
provid
dr
takato
odagiri
nation
institut
infecti
diseas
tokyo
japan
intranas
administr
mice
euthan
intraperiton
administr
sodium
pentobarbit
day
ifv
infect
whole
lung
collect
paraffin
embed
hematoxylin
eosin
stain
tissu
perform
use
standard
methodolog
bal
carri
describ
brief
trachea
mice
cannul
diamet
polyethylen
cathet
lung
instil
ml
prewarm
phosphat
buffer
salin
pb
contain
mm
ethylenediaminetetraacet
acid
follow
retriev
lavag
fluid
aliquot
cell
bal
fluid
balf
count
red
blood
cell
lysi
subject
flow
cytometr
analysi
supernat
balf
subject
multi
cytokinechemokin
express
analysi
enzymelink
immunosorb
assay
elisa
balf
cell
suspend
mous
fcr
block
reagent
miltenyi
biotec
bergisch
gladbach
germani
min
prior
stain
fitc
pe
biotin
antibodi
stain
biotinyl
antibodi
visual
streptavidinenergycoupl
dye
beckman
coulter
fullerton
ca
antibodi
use
stain
cell
analys
cytom
flow
cytomet
beckman
coulter
flowjo
softwar
tree
star
ashland
cytokinechemokin
interferon
level
balf
measur
flow
cytomix
cytokin
bead
assay
bender
medsystem
vienna
austria
cell
cultur
supernat
bmmf
assay
use
specif
elisa
kit
biolegend
r
system
minneapoli
mn
measur
perform
triplic
lung
tissu
collect
day
ifv
infect
homogen
use
gentlemac
dissoci
miltenyi
biotec
rna
extract
use
isogen
ii
rna
extract
kit
nippon
gene
tokyo
japan
revers
transcript
conduct
primer
aaa
agc
qpcr
perform
primer
specif
influenza
nucleoprotein
gene
np
forward
tgg
tgg
aat
tgg
acg
revers
gca
cca
ttc
tct
cta
use
appli
biosystem
fast
real
time
pcr
system
life
technolog
carlsbad
ca
standard
calibr
curv
qpcr
obtain
stepwis
dilut
clone
np
gene
fragment
known
copi
number
b
cellmedi
humor
respons
measur
virionspecif
immunoglobulin
product
elisa
previous
briefli
elisa
plate
corn
corn
ny
coat
ultrason
influenza
virion
strain
pfuml
carbon
buffer
ph
incub
overnight
plate
wash
pb
contain
tween
wako
serum
balf
collect
mice
day
secondari
infect
serial
dilut
pbstween
contain
skim
milk
appli
onto
virionco
plate
incub
h
room
temperatur
wash
goat
antimous
total
igg
iga
conjug
horseradish
peroxidas
jackson
immunoresearch
baltimor
pike
pa
appli
incub
h
room
temperatur
wash
plate
stain
tmb
substrat
set
biolegend
reaction
termin
wako
absorb
measur
amf
isol
balf
wt
mice
tgmf
prepar
bmmf
cdc
prepar
cultur
bone
marrow
cell
day
medium
wako
supplement
foetal
bovin
serum
life
technolog
antibiot
iuml
penicillin
streptomycin
sigmaaldrich
contain
mcsf
ngml
peprotech
rocki
hill
nj
gmcsf
ngml
peprotech
human
ngml
peprotech
respect
mfdc
stimul
cell
seed
cultur
plate
corn
incub
overnight
follow
replac
serumfre
medium
contain
pfu
multipl
infect
moi
ifv
h
incub
unabsorb
virus
remov
cell
incub
h
serumcontain
medium
bmmf
also
stimul
lp
ngml
poli
c
imiquimod
h
serumcontain
medium
chemic
reagent
treatment
bmmf
incub
oligomycin
aicar
mm
bay
h
prior
viru
stimul
cultur
supernat
assay
elisa
total
rna
extract
cell
use
reliaprep
rna
cell
miniprep
system
promega
madison
wi
cdna
synthes
superscript
ii
life
technolog
random
primer
rt
product
subject
qpcr
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
use
sybr
green
pcr
master
mix
abi
specif
primer
gene
pcr
product
sequenc
homogen
confirm
monitor
dissoci
temperatur
sybr
green
fluoresc
primer
sequenc
follow
mous
forward
tcc
ttc
cta
ccc
caa
ttt
revers
gtc
ctt
agc
cac
tcc
tnf
forward
cct
gta
gcc
cac
gtc
revers
acc
act
agt
tgg
ttg
tct
forward
caa
gaa
gga
atg
ggt
revers
tgt
gga
aaa
ggt
agt
actb
forward
tca
aga
tca
ttg
ctc
ctc
revers
cag
ctc
agt
aac
agt
bmmf
prepar
describ
stimul
ifv
moi
h
incub
bmmf
harvest
cell
scraper
nuclear
cytoplasm
extract
bmmf
perform
use
nuclear
extract
kit
activ
motif
carlsbad
ca
accord
manufactur
instruct
nuclear
cytoplasm
extract
separ
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
transfer
membran
filter
analys
immunoblot
rabbit
antibodi
clone
mous
antibodi
clone
rabbit
antibodi
clone
rabbit
antibodi
clone
mous
antibodi
clone
rabbit
antibodi
clone
rabbit
antibodi
clone
rabbit
antibodi
clone
obtain
cell
signal
technolog
mous
antilamin
ac
antibodi
clone
activ
motif
mous
antibodi
merck
millipor
bmmf
prepar
describ
stimul
ifv
moi
h
incub
bmmf
harvest
cell
scraper
atp
level
determin
use
atp
bioluminesc
assay
kit
cl
ii
roch
appli
scienc
upper
bavaria
germani
previous
atp
level
normal
total
protein
concentr
determin
use
bradford
assay
kit
biorad
laboratori
hercul
ca
surviv
curv
gener
kaplanmei
method
statist
analys
perform
use
logrank
test
statist
signific
assess
student
ttest
p
valu
consid
signific
cite
articl
uematsu
et
al
deplet
amelior
sever
murin
influenza
pneumonia
macrophag
cytokin
product
respons
influenza
viru
sci
rep
doi
publish
note
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
